Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Controlled Trial to Evaluate the Effects of GanedenBC30 on the Immune System

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2010 by AIDS Healthcare Foundation.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Ganeden Biotech, Inc.
Information provided by:
AIDS Healthcare Foundation
ClinicalTrials.gov Identifier:
NCT01184456
First received: August 17, 2010
Last updated: NA
Last verified: August 2010
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2011
  Estimated Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)